A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma
Crossref DOI link: https://doi.org/10.1007/s10147-017-1138-6
Published Online: 2017-05-23
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Horimatsu, Takahiro
Nakayama, Norisuke
Moriwaki, Toshikazu
Hirashima, Yoshinori
Fujita, Mikio
Asayama, Masako
Moriyama, Ichiro
Nakashima, Koji
Baba, Eishi
Kitamura, Hiroshi
Tamura, Takao
Hosokawa, Ayumu
Yoshimura, Kenichi
Muto, Manabu
License valid from 2017-05-23